EP3682884
CRYSTALLINE FORMS OF DAPRODUSTAT (GSK1278863), A PERORAL HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR (HIF-PHI) FOR TREATING ANEMIA, AND THEIR PREPARATION METHODS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.3.2018EP published:
24.4.2024EP application number:
18857375.2
EPO information:
European Patent Register
Max expiry date:
12.3.2038
Title in English:
CRYSTALLINE FORMS OF DAPRODUSTAT (GSK1278863), A PERORAL HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR (HIF-PHI) FOR TREATING ANEMIA, AND THEIR PREPARATION METHODSLanguage of the patent:
English
Timeline
Today
13.3.2018EP application
24.4.2024EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property (No. 2) LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
CHEN, MinhuaAddress:
Suzhou Jiangsu 215123, CN
Name:
ZHANG, YanfengAddress:
Suzhou Jiangsu 215123, CN
Name:
WANG, JinqiuAddress:
Suzhou Jiangsu 215123, CN
Name:
ZHANG, XiaoyuAddress:
Suzhou Jiangsu 215123, CN
Priority
Number:
201710835313Date:
15.9.2017Country:
CN
Classification
Categories:
C07D 239/62, A61K 31/515, A61P 7/06